SC 13G: Cadrenal Therapeutics, Inc.

AI Summary

SC 13G filing by Cadrenal Therapeutics, Inc..

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.001 — ame of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti

Filing Documents

• ea0216479-13ghavlic_cadrenal.htm (SC 13G) — 80KB
• 0001213900-24-085556.txt ( ) — 81KB

(a) Name of Issuer

Item 1. (a) Name of Issuer Cadrenal Therapeutics, Inc. (the “Issuer”)

(b) Address of Issuer’s Principal Executive Offices

Item 1. (b) Address of Issuer’s Principal Executive Offices 822 A1A North, Suite 306 Ponte Vedra, Florida 32082

(a) Names of Person Filing

Item 2. (a) Names of Person Filing: Havlickova 648 a.s. Dubnica Property s.r.o. Miroslav Dornak Collectively, the “Reporting Persons”

(b) Address of Principal Business Office or, if None, Residence

Item 2. (b) Address of Principal Business Office or, if None, Residence: Havlickova 648 a.s. U Rustonky 714/1 186 00, Prague Czech Republic Dubnica Property s.r.o. U Rustonky 714/1 186 00, Prague Czech Republic Miroslav Dornak U Rustonky 714/1 186 00, Prague Czech Republic

(c) Citizenship

Item 2. (c) Citizenship: Havlickova 648 a.s. – Czech Republic Dubnica Property s.r.o. – Czech Republic Miroslav Dornak – Czech Republic

(d) Title of Class of Securities

Item 2. (d) Title of Class of Securities: Common Stock, par value $0.001 per share (“Shares”)

(e) CUSIP Number

Item 2. (e) CUSIP Number: 127636207 CUSIP No. 127636207 SCHEDULE 13G Page 6 of 9 Pages

If this statement is filed pursuant to §§240.13d-1(b)

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J); (k) A group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: __________________

Ownership

Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned as of October 3, 2024: Havlickova 648 a.s. – 66,332 Dubnica Property s.r.o. – 66,332 Miroslav Dornak – 66,332 (b) Percent of Class as of October 3, 2024: Havlickova 648 a.s. – 6.2% Dubnica Property s.r.o. – 6.2% Miroslav Dornak – 6.2% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: Havlickova 648 a.s. – 0 Dubnica Property s.r.o. – 0 Miroslav Dornak – 0 (ii) Shared power to vote or to direct the vote: Havlickova 648 a.s. – 66,332 Dubnica Property s.r.o. – 66,332 Miroslav Dornak – 66,332 CUSIP No. 127636207 SCHEDULE 13G Page 7 of 9 Pages (iii) Sole power to dispose or to direct the disposition of: Havlickova 648 a.s. – 0 Dubnica Property s.r.o. – 0 Miroslav Dornak – 0 (iv) Shared power to dispose or to direct the disposition of: Havlickova 648 a.s. – 66,332 Dubnica Property s.r.o. – 66,332 Miroslav Dornak – 66,332 The percentage of Shares reported to be beneficially owned by the Reporting Persons are based on 1,067,231 Shares of the Issuer outstanding as of August 20, 2024, based on information reported on the Issuer’s Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on August 7, 2024, as well as based on information reported on the Issuer’s Form 8-K filed with the SEC on August 20, 2024 regarding the Issuer’s 1-for-15 reverse stock split. Havlickova 648 a.s. directly holds 66,332 Shares of the Issuer. Dubnica Property s.r.o. is the direct parent of Havlickova 648 a.s. and controls the voting and dispositive power of the 66,332 Shares of the Issuer held by Havlickova 648 a.s. Miroslav Dornak also controls the voting and dispositive powe

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following .

Ownership of More Than Five Percent on Behalf of Another Person

Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Not Applicable.

Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by

Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not Applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group. Not Applicable.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group. Not Applicable.

Certifications

Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. CUSIP No. 127636207 SCHEDULE 13G Page 8 of 9 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: October 4, 2024 Havlickova 648 a.s. By: /s/ Miroslav Dornak Miroslav Dornak Authorized Signatory Dubnica Property s.r.o. By: /s/ Miroslav Dornak Miroslav Dornak Authorized Signatory By: /s/ Cyril Florent Vladimir Dejanovski Cyril Florent Vladimir Dejanovski Authorized Signatory By: /s/ Miroslav Dornak Miroslav Dornak Exhibit 1 JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning such person contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that such person knows or has reason to believe that such information is inaccurate. Dated: October 4, 2024 Havlickova 648 a.s. By: /s/ Miroslav Dornak Miroslav Dornak Authorized Signatory Dubnica Pr

View Full Filing

View this SC 13G filing on SEC EDGAR